Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518132, China.
Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen 518132, China; Department of Chemical and Biological Engineering, Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR 999077, China.
Cell Rep Methods. 2024 Jun 17;4(6):100793. doi: 10.1016/j.crmeth.2024.100793. Epub 2024 Jun 11.
Plasma cell-free DNA (cfDNA) fragmentation patterns are emerging directions in cancer liquid biopsy with high translational significance. Conventionally, the cfDNA sequencing reads are aligned to a reference genome to extract their fragmentomic features. In this study, through cfDNA fragmentomics profiling using different reference genomes on the same datasets in parallel, we report systematic biases in such conventional reference-based approaches. The biases in cfDNA fragmentomic features vary among races in a sample-dependent manner and therefore might adversely affect the performances of cancer diagnosis assays across multiple clinical centers. In addition, to circumvent the analytical biases, we develop Freefly, a reference-free approach for cfDNA fragmentomics profiling. Freefly runs ∼60-fold faster than the conventional reference-based approach while generating highly consistent results. Moreover, cfDNA fragmentomic features reported by Freefly can be directly used for cancer diagnosis. Hence, Freefly possesses translational merit toward the rapid and unbiased measurement of cfDNA fragmentomics.
血浆无细胞游离 DNA (cfDNA) 碎片化模式是癌症液体活检中的新兴方向,具有重要的转化意义。传统上,cfDNA 测序读段会与参考基因组进行比对,以提取其片段组学特征。在这项研究中,通过在同一数据集上使用不同的参考基因组平行进行 cfDNA 片段组学分析,我们报告了这种传统基于参考的方法中存在的系统偏差。cfDNA 片段组学特征的偏差在样本中的不同种族之间存在差异,因此可能会对多个临床中心的癌症诊断检测的性能产生不利影响。此外,为了规避分析偏差,我们开发了一种无参考的 cfDNA 片段组学分析方法 Freefly。Freefly 的运行速度比传统的基于参考的方法快约 60 倍,同时生成高度一致的结果。此外,Freefly 报告的 cfDNA 片段组学特征可直接用于癌症诊断。因此,Freefly 具有快速、无偏地测量 cfDNA 片段组学的转化价值。